Intuitive Surgical, Inc. (ISRG) Receives $554.64 Consensus PT from Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned an average recommendation of “Buy” from the twenty-two ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seventeen have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $554.64.

ISRG has been the topic of several recent research reports. Piper Jaffray Companies upped their price objective on Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a research report on Wednesday, October 31st. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, October 21st. Royal Bank of Canada restated a “hold” rating and issued a $560.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 19th. Raymond James upped their price objective on Intuitive Surgical from $620.00 to $630.00 and gave the company an “outperform” rating in a research report on Friday, October 19th. Finally, Canaccord Genuity upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and upped their price objective for the company from $550.00 to $610.00 in a research report on Friday, October 19th. They noted that the move was a valuation call.

ISRG traded down $5.64 during trading on Monday, reaching $540.04. 95,672 shares of the stock were exchanged, compared to its average volume of 1,093,480. The company has a market cap of $59.35 billion, a price-to-earnings ratio of 75.11, a PEG ratio of 3.49 and a beta of 1.02. Intuitive Surgical has a 1 year low of $359.75 and a 1 year high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. The company had revenue of $920.90 million for the quarter, compared to the consensus estimate of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. Intuitive Surgical’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.77 earnings per share. Equities analysts anticipate that Intuitive Surgical will post 9.52 EPS for the current fiscal year.

In related news, VP Jamie Samath sold 864 shares of the company’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total value of $431,317.44. Following the completion of the transaction, the vice president now directly owns 257 shares in the company, valued at $128,296.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 350 shares of the company’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $560.00, for a total value of $196,000.00. Following the completion of the transaction, the director now owns 4,316 shares of the company’s stock, valued at $2,416,960. The disclosure for this sale can be found here. Insiders sold 47,086 shares of company stock valued at $24,023,337 over the last quarter. Insiders own 2.20% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Adviser Investments LLC acquired a new position in Intuitive Surgical in the second quarter valued at $115,000. Signet Financial Management LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $115,000. Arrow Financial Corp acquired a new stake in Intuitive Surgical during the third quarter worth about $115,000. JNBA Financial Advisors acquired a new stake in Intuitive Surgical during the third quarter worth about $115,000. Finally, Pendal Group Ltd acquired a new stake in Intuitive Surgical during the third quarter worth about $118,000. Hedge funds and other institutional investors own 84.16% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

See Also: How Do I Invest in Dividend Stocks

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply